Bellen Chemistry
PrivateLast Round
Series D
Extension
Aug 19, 2020
Est. Valuation
$360.2M
Total Funding Raised
$75.5M
Company Overview
Bellen Chemistry operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series D Extension round in August 2020.
Bellen Chemistry is a pharmaceutical and biotechnology company that provides integrated contract research, development, and manufacturing services for small molecule drug discovery and commercialization.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bellen Chemistry Comparables
Compare Bellen Chemistry with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lewei Pharmaceutical | 86% | |
| Sai Life Sciences | 86% | |
| WuXi AppTec | 83% |
For institutional investors. Book with your work email.
Bellen Chemistry Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Aug 19, 2020 | ||||
| Series D | Jun 30, 2020 | ||||
| Series C | Sep 27, 2018 | ||||
| Series B | Sep 22, 2017 | ||||
| Series A | Jul 1, 2016 |
For institutional investors. Book with your work email.
Bellen Chemistry Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series D Extension |
| Boxin Capital | Series D, Series A |
| Gopher Asset Management | Series B |
| 招银国际金融有限公司 | Series C |
| Legend Capital | Series D, Series C, Series B |
| Shenzhen Dachen Caizhi Venture Capital Management | Series B |
| CICC Capital | Series D, Series B, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Monthly visitors increased 51% MoM, reaching 1.4K.
- Mar 17, 2025
Monthly visitors increased 64% MoM.
For institutional investors. Book with your work email.
Bellen Chemistry Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bellen Chemistry's valuation, stock price, and market status.
Is Bellen Chemistry a public or private company?
Bellen Chemistry is a private company.
What is the current stock price of Bellen Chemistry?
Bellen Chemistry is a private company, so its shares have no public market price. Caplight tracks Bellen Chemistry's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bellen Chemistry worth (valuation)?
Bellen Chemistry's valuation is estimated at $360.2M based on funding round data.
Can I buy Bellen Chemistry stock?
Bellen Chemistry shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bellen Chemistry's last funding round?
Bellen Chemistry's most recent funding round was Series D Extension on August 19, 2020.
Who are the main investors in Bellen Chemistry?
Key investors in Bellen Chemistry include HighLight Capital, 招银国际金融有限公司, Legend Capital, Apricot Capital.
Will Bellen Chemistry IPO soon?
No public IPO plans have been announced for Bellen Chemistry.
How can I track Bellen Chemistry secondary market activity?
Caplight tracks bids, offers, and trades in Bellen Chemistry's shares on secondary markets.